Design and conduct experiments, analyze and present data, write manuscripts and a training grant.
Responsible to lead one of Dr. Shane McAllister's lab projects in the Pediatric Infectious Diseases Division under his direction. Dr. McAllister's laboratory studies viral oncogenesis and is currently focused on the generic beta blocker propranolol, which is a promising agent for the treatment of Kaposi sarcoma and primary effusion lymphoma, two cancers associated with Kaposi sarcoma herpesvirus/homun herpesvirus 8 infection.
PhD and/or M.D.
Demonstrated productive publication history.
Experience with molecular techniques (qPCR, immunoblotting, cloning, etc.), flow cytometry, and cell culture is required.
Experience working with viral pathogens and murine models is highly desirable.
Internal Number: 307716
About University of Minnesota, Twin Cities
The University of Minnesota, founded in the belief that all people are enriched by understanding, is dedicated to the advancement of learning and the search for truth; to the sharing of this knowledge through education for a diverse community; and to the application of this knowledge to benefit the people of the state, the nation, and the world.